Metastatic pancreatic cancer remains a difficult disease to treat; however, there are more new drug combinations on thehorizon each week. We will discuss the results of the MPACT trial presented at the 2013 ASCO Annual Meeting (Abstracts#4005, #4058, and #4059) and compare to the 2011 FOLFIRINOX data.
Muhammad Wasif Saif, Jamie Jarboe
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2019 All rights reserved. iMedPub LTD Last revised : September 22, 2019